The 6th International Genitourinary Cancer Conference (IGCC 2026) returns to the Hilton Hotel in Jeddah, Saudi Arabia, from 19 to 21 November 2026. Held under the Saudi Oncology Society and organised by Live Presentation, the conference has grown over five previous editions into one of the region's dedicated meetings for urologic oncology, bringing Saudi, Gulf and international experts together around the cancers of the prostate, bladder, kidney, upper urinary tract, testis and penis.
IGCC is built around a multidisciplinary audience. The official materials name six target groups: medical oncologists, urologists, radiation oncologists, clinical pharmacists, pathologists and nurses. Previous editions have reflected that mix, pairing updates in systemic therapy, immunotherapy and precision medicine with surgical technique and innovation in urologic oncology, advanced radiotherapy approaches such as SBRT and IMRT, molecular diagnostics and tumour profiling in pathology, oncology pharmacotherapy and drug interactions, and patient-centred nursing care and symptom management.
The 2025 edition, held at the same venue, featured a faculty of internationally recognised genitourinary oncology leaders alongside consultants from major Saudi cancer centres, and an exhibition area supported by industry partners. The faculty, scientific programme and sponsors for the 2026 edition have not yet been published by the organiser; this listing will be updated when they are announced.
Registration for IGCC 2026 is open through the official registration portal, which currently lists a registration fee of SAR 0 (free). Delegates are asked to provide their profession, workplace and SCFHS number, and attendees from outside Saudi Arabia without an SCFHS ID may upload a passport instead. The conference flyer states that CME hours are accredited; the number of hours and the accrediting body have not yet been published, so no credit total is shown here.
For oncologists, urologists and allied cancer-care professionals in Saudi Arabia and the Gulf, IGCC offers three days of focused genitourinary cancer education in Jeddah, with the opportunity to discuss practice-changing evidence and multidisciplinary care pathways with peers and international experts.
